(Q34612314)

3 August 2017

1 reference

title

Predictive and prognostic markers for invasive breast cancer (English)

1 reference

3 August 2017

Ichiro Mori

1

1 reference

3 August 2017

Qifeng Yang

series ordinal

2

1 reference

3 August 2017

Kennichi Kakudo

series ordinal

3

1 reference

3 August 2017

language of work or name

1 reference

1 March 2002

1 reference

3 August 2017

published in

Pathology International

1 reference

3 August 2017

volume

52

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

186-194

1 reference

The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Routinely available indicators of prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Cytology of Ki-1 (CD-30) positive large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Histologic grading of breast carcinoma. A reproducibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

The efficacy and limitations of repeated slide conferences for improving interobserver agreement when judging nuclear atypia of breast cancer. The Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Monitoring of interobserver agreement in nuclear atypia scoring of node-negative breast carcinomas judged at individual collaborating hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Confirmation of a prognostic index in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

An approach for the treatment of penile carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Sentinel lymph node biopsy in breast cancer: an overview of the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Lymph node micrometastases from breast carcinoma: reviewing the dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

The long term prognostic significance of c-erbB-2 in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

ER beta: identification and characterization of a novel human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Prostate-specific antigen expression is regulated by an upstream enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Thymidine phosphorylase is angiogenic and promotes tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Angiogenic activity of enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Development and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Thymidine phosphorylase expression correlates with tumor differentiation and Bcl-2 in invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Prognostic value of thymidine phosphorylase expression in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Replacement of Fhit in cancer cells suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Loss of heterozygosity in normal tissue adjacent to breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Expression of Retinoid Receptor Genes and Proteins in Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta2 expression in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Drug-target interactions: only the first step in the commitment to a programmed cell death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Apoptosis. Biochemical events and relevance to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Detection of prostate-specific antigen immunoreactivity in breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01335.X

10.1046/J.1440-1827.2002.01335.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference